• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Chinese herbal medicine supplementation therapy on COVID-19.中药补充疗法治疗新型冠状病毒肺炎
Pharmacol Res. 2020 Oct;160:105181. doi: 10.1016/j.phrs.2020.105181. Epub 2020 Aug 29.
2
Dangers of scientific bias against herbal drugs for coronavirus disease 2019.科学偏见对 2019 冠状病毒病草药的危害。
J Integr Med. 2020 Nov;18(6):459-461. doi: 10.1016/j.joim.2020.09.005. Epub 2020 Sep 18.
3
Use of herbal drugs to treat COVID-19 should be with caution.使用草药治疗新冠病毒疾病时应谨慎。
Lancet. 2020 May 30;395(10238):1689-1690. doi: 10.1016/S0140-6736(20)31143-0. Epub 2020 May 15.
4
East meets West in COVID-19 therapeutics.在新冠病毒治疗中，东西方相遇了。
Pharmacol Res. 2020 Sep;159:105008. doi: 10.1016/j.phrs.2020.105008. Epub 2020 Jun 9.
5
Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.促进中药抗COVID-19机制研究的数据库
Pharmacol Res. 2020 Sep;159:104989. doi: 10.1016/j.phrs.2020.104989. Epub 2020 Jun 2.
6
Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients.基于网络药理学方法阐释中药治疗新冠肺炎患者的作用机制
Pharmacol Res. 2020 Sep;159:105043. doi: 10.1016/j.phrs.2020.105043. Epub 2020 Jun 20.
7
Traditional Chinese Medicine treatment of COVID-19.中医药治疗 COVID-19。
Complement Ther Clin Pract. 2020 May;39:101165. doi: 10.1016/j.ctcp.2020.101165. Epub 2020 Apr 1.
8
The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19.基于数据库的策略可能高估了中药对新冠病毒的潜在作用。
Pharmacol Res. 2020 Sep;159:105046. doi: 10.1016/j.phrs.2020.105046. Epub 2020 Jun 23.
9
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].[中草药及其活性成分干预人类冠状病毒的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.
10
In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.基于分子对接的针对 SARS-CoV-2 3CLpro 和血管紧张素转化酶 II 的新冠病毒潜在中草药的计算机筛选
Chin J Integr Med. 2020 Jul;26(7):527-532. doi: 10.1007/s11655-020-3476-x. Epub 2020 Jul 6.

引用本文的文献

1
It Was Like Going to a Battlefield: Lived Experience of Frontline Nurses Supporting Two Hospitals in Wuhan During the COVID-19 Pandemic.这就像奔赴战场：新冠疫情期间一线护士支援武汉两家医院的亲身经历。
SAGE Open Nurs. 2024 May 20;10:23779608241253977. doi: 10.1177/23779608241253977. eCollection 2024 Jan-Dec.
2
Traditional Chinese medicine in COVID-19.中医药在新型冠状病毒肺炎中的应用
Acta Pharm Sin B. 2021 Nov;11(11):3337-3363. doi: 10.1016/j.apsb.2021.09.008. Epub 2021 Sep 20.
3
The therapeutic efficacy of Huashi Baidu Formula combined with antiviral drugs in the treatment of COVID-19: A protocol for systematic review and meta-analysis.化湿败毒方联合抗病毒药物治疗新型冠状病毒肺炎的疗效：系统评价与Meta分析方案
Medicine (Baltimore). 2020 Oct 16;99(42):e22715. doi: 10.1097/MD.0000000000022715.

本文引用的文献

1
Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis.中药治疗 2019 年冠状病毒病：系统评价和荟萃分析。
Pharmacol Res. 2020 Oct;160:105056. doi: 10.1016/j.phrs.2020.105056. Epub 2020 Jul 2.
2
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 声明：平行组随机试验报告的更新指南。
BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.
3
Meta-analysis in clinical trials.临床试验中的荟萃分析。
Control Clin Trials. 1986 Sep;7(3):177-88. doi: 10.1016/0197-2456(86)90046-2.

Chinese herbal medicine supplementation therapy on COVID-19.

作者信息

Yu Mingyang, Zhang Rongguang, Ni Peng, Duan Guangcai

机构信息

Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China.

Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, China; College of Public Health, Hainan Medical University, Haikou 571199, China.

出版信息

Pharmacol Res. 2020 Oct;160:105181. doi: 10.1016/j.phrs.2020.105181. Epub 2020 Aug 29.

DOI:10.1016/j.phrs.2020.105181
PMID:32866599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7455541/
Abstract
摘要